Web Site Offers Clinical Trial Details to the Public

Ken Rankin
Published Online: Tuesday, November 1, 2005

Pharmacists, as well as patients, are now able to quickly obtain details of clinical trials for new medicines in development via a new Web site established by the pharmaceutical industry. This Internet site, www.ifpma.org/ clinicaltrials, provides detailed information about most, but not all, clinical studies under way by the global pharmaceutical industry. By making this information more easily accessible to the public, drugmakers hope to allay consumer concerns over the safety of new pharmaceuticals.

Those concerns spiked earlier this year following the withdrawal of Vioxx and disclosures of serious side effects associated with other pain medications on the market. Created by the International Federation of Pharmaceutical Manufacturers and Associations, the new Web site is designed to enable patients to learn about opportunities to participate in clinical trials for drugs being studied to treat their conditions.

Mr. Rankin is a freelance medical writer.

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues